Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

Rinella, 2015, Non-alcoholic fatty liver disease: a systematic review, JAMA, 313, 2263, 10.1001/jama.2015.5370

Lonardo, 2015, Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups, Dig Liver Dis, 47, 997, 10.1016/j.dld.2015.08.004

Anstee, 2013, Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nat Rev Gastroenterol Hepatol, 10, 330, 10.1038/nrgastro.2013.41

Targher, 2010, Risk of cardiovascular disease in patients with non-alcoholic fatty liver disease, N Engl J Med, 363, 1341, 10.1056/NEJMra0912063

Byrne, 2015, NAFLD: a multisystem disease, J Hepatol, 62, S47, 10.1016/j.jhep.2014.12.012

Ballestri, 2014, Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease, World J Gastroenterol, 20, 1724, 10.3748/wjg.v20.i7.1724

Ballestri, 2016, Non-alcoholic fatty liver disease is associated with an almost two-fold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis, J Gastroenterol Hepatol, 31, 936, 10.1111/jgh.13264

Oni, 2013, A systematic review: burden and severity of subclinical cardiovascular disease among those with non-alcoholic fatty liver; should we care?, Atherosclerosis, 230, 258, 10.1016/j.atherosclerosis.2013.07.052

Puchner, 2015, High-risk coronary plaque at coronary CT angiography is associated with non-alcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial, Radiology, 274, 693, 10.1148/radiol.14140933

Lonardo, 2015, Non-alcoholic fatty liver disease and risk of cardiovascular disease, Metabolism

Tahan, 2008, Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk, Hepatogastroenterology, 55, 1433

Castera, 2013, Noninvasive evaluation of NAFLD, Nat Rev Gastroenterol Hepatol, 10, 666, 10.1038/nrgastro.2013.175

Keramida, 2014, Accumulation of (18)F-FDG in the liver in hepatic steatosis, AJR Am J Roentgenol, 203, 643, 10.2214/AJR.13.12147

Hong, 2014, Hepatic glucose uptake is increased in association with elevated serum γ-glutamyltranspeptidase and triglyceride, Dig Dis Sci, 59, 607, 10.1007/s10620-013-2957-6

Higgins JPT, Green S, (eds.) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from www.cochrane-handbook.org.

Wells, 2013, Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews, Res Synth Methods, 4, 63, 10.1002/jrsm.1077

Greenland, 1987, Variance estimators for attributable fraction estimates consistent in both large strata and sparse data, Stat Med, 6, 701, 10.1002/sim.4780060607

Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186

Furukawa, 2002, Can we individualize the ’number needed to treat’? An empirical study of summary effect measures in meta-analyses, Int J Epidemiol, 31, 72, 10.1093/ije/31.1.72

Egger, 1997, Meta-analysis: principles and procedures, BMJ, 315, 1533, 10.1136/bmj.315.7121.1533

Jepsen, 2003, Prognosis of patients with a diagnosis of fatty liver—a registry-based cohort study, Hepatogastroenterology, 50, 2101

Targher, 2007, Non-alcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients, Diabetes Care, 30, 2119, 10.2337/dc07-0349

Hamaguchi, 2007, Non-alcoholic fatty liver disease is a novel predictor of cardiovascular disease, World J Gastroenterol, 13, 1579, 10.3748/wjg.v13.i10.1579

Haring, 2009, Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyltranspeptidase levels, Hepatology, 50, 1403, 10.1002/hep.23135

Adams, 2010, Non-alcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study, Am J Gastroenterol, 105, 1567, 10.1038/ajg.2010.18

Lazo, 2011, Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study, BMJ, 343, d6891, 10.1136/bmj.d6891

Zhou, 2012, Natural course of non-alcoholic fatty liver disease in southern China: a prospective cohort study, J Dig Dis, 13, 153, 10.1111/j.1751-2980.2011.00571.x

El Azeem, 2013, Association between non-alcoholic fatty liver disease and the incidence of cardiovascular and renal events, J Saudi Heart Assoc, 25, 239, 10.1016/j.jsha.2013.07.004

Pisto, 2014, Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study, BMJ Open, 4, 10.1136/bmjopen-2014-004973

Pickhardt, 2014, Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications, AJR Am J Roentgenol, 202, 752, 10.2214/AJR.13.11367

Wong, 2016, Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: a prospective cohort study, Hepatology, 63, 754, 10.1002/hep.28253

Moon, 2015, Association between non-alcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluoro-deoxyglucose positron emission tomography, Angiology, 66, 472, 10.1177/0003319714537872

Ekstedt, 2015, Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up, Hepatology, 61, 1547, 10.1002/hep.27368

Emre, 2015, Impact of non-alcoholic fatty liver disease on myocardial perfusion in nondiabetic patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction, Am J Cardiol, 116, 1810, 10.1016/j.amjcard.2015.09.021

Zeb, 2016, Non-alcoholic fatty liver disease and incident cardiac events: The Multi-Ethnic Study of Atherosclerosis, J Am Coll Cardiol, 67, 1965, 10.1016/j.jacc.2016.01.070

Fracanzani, 2016, Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up, Atherosclerosis, 246, 208, 10.1016/j.atherosclerosis.2016.01.016

Kim, 2013, Association between non-invasive fibrosis markers and mortality among adults with non-alcoholic fatty liver disease in the United States, Hepatology, 57, 1357, 10.1002/hep.26156

Ghouri, 2010, Liver enzymes, non-alcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data, Hepatology, 52, 1156, 10.1002/hep.23789

Musso, 2011, Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity, Ann Med, 43, 617, 10.3109/07853890.2010.518623

Lu, 2013, Independent association between non-alcoholic fatty liver disease and cardiovascular disease: a systematic review and meta-analysis, Int J Endocrinol, 2013, 124958, 10.1155/2013/124958

Younossi, 2015, Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence and outcomes, Hepatology

Stepanova, 2012, Independent association between non-alcoholic fatty liver disease and cardiovascular disease in the US population, Clin Gastroenterol Hepatol, 10, 646, 10.1016/j.cgh.2011.12.039

Younossi, 2013, In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not, Metabolism, 62, 352, 10.1016/j.metabol.2012.08.005

Wong, 2011, Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease, Gut, 60, 1721, 10.1136/gut.2011.242016

Ekstedt, 2006, Long-term follow-up of patients with NAFLD and elevated liver enzymes, Hepatology, 44, 865, 10.1002/hep.21327

Soderberg, 2010, Decreased survival of subjects with elevated liver function tests during a 28-year follow-up, Hepatology, 51, 595, 10.1002/hep.23314

Matteoni, 1999, Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8

Rafiq, 2009, Long-term follow-up of patients with non-alcoholic fatty liver, Clin Gastroenterol Hepatol, 7, 234, 10.1016/j.cgh.2008.11.005

Adams, 2005, The natural history of non-alcoholic fatty liver disease: a population-based cohort study, Gastroenterology, 129, 113, 10.1053/j.gastro.2005.04.014

Angulo, 2015, Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with non-alcoholic fatty liver disease, Gastroenterology, 149, 389, 10.1053/j.gastro.2015.04.043

Byrne, 2014, Ectopic fat, insulin resistance, and non-alcoholic fatty liver disease: implications for cardiovascular disease, Arterioscler Thromb Vasc Biol, 34, 1155, 10.1161/ATVBAHA.114.303034

VanWagner, 2015, Association of non-alcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study, Hepatology, 62, 773, 10.1002/hep.27869

Targher, 2013, Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes, PLoS One, 8, 10.1371/journal.pone.0057183

Mantovani, 2015, Heart valve calcification in patients with type 2 diabetes and non-alcoholic fatty liver disease, Metabolism, 64, 879, 10.1016/j.metabol.2015.04.003

Lonardo, 2015, Diagnosis and management of cardiovascular risk in non-alcoholic fatty liver disease, Expert Rev Gastroenterol Hepatol, 9, 629, 10.1586/17474124.2015.965143

Singh, 2015, Fibrosis progression in non-alcoholic fatty liver vs. non-alcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies, Clin Gastroenterol Hepatol, 13, 643, 10.1016/j.cgh.2014.04.014